SEC Filing Summary: Heatwurx, Inc. (Form 8-K)
Business Context and Reporting Period
This Form 8-K was filed by Heatwurx, Inc. on October 28, 2013. The registrant is incorporated in Delaware and maintains its principal executive offices in Greenwood Village, Colorado. The filing serves as a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Note: The request metadata referenced "Processa Pharmaceuticals, Inc.," but the filing text explicitly identifies the registrant as Heatwurx, Inc.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a disclosure of a specific corporate event and does not contain financial statements or performance metrics.
Material Changes
The material change reported is the granting of an additional patent to Heatwurx, Inc. by the U.S. Patent and Trademark Office. This event was announced via a press release issued on October 28, 2013, which is attached as Exhibit 99.1.
Guidance, Outlook, and Risks
The filing does not contain financial guidance, future outlook, management commentary on operations, or specific risk factors beyond the standard regulatory language. The information provided is strictly limited to the patent grant announcement and is not deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Verify the specific details and scope of the patent granted by reviewing the attached press release (Exhibit 99.1).
- Confirm the registrant name is Heatwurx, Inc., not Processa Pharmaceuticals, Inc.
- Check subsequent filings for any financial impact or commercialization plans related to the new patent.